This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Moderna is working on restoring investors' faith that its Covid-19 vaccine was n...
A series of actions by President Donald Trump's administration have provoked pro...
The lab of Nobel laureate David Baker keeps pushing the limits of what's possibl...
Knownwell, the Andreessen Horowitz and Flare Capital Partners-backed metabolic h...
The Senate on Thursday confirmed Robert F. Kennedy Jr. as Secretary of Health an...
Agios' blood disease treatment Pyrukynd passed a Phase 3 study in PK deficiency ...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...
Plus, news about Pliant Therapeutics, Blueprint Medicines, Galapagos and Atai: ...
Idorsia’s plan to hand over the global rights to its blood pressure drug Tryvio ...
In a surprise move Thursday, Neumora remade its executive team and brought back ...
Sanofi has been hit with a $250 million impairment charge after an E. coli vacci...
Aardvark Therapeutics, a biotech looking to address hunger rather than appetite ...
Newleos Therapeutics emerged Thursday with $93.5 million and a bundle of oral sm...
Simon Kohl turned an internship at Google DeepMind into a key role in building A...
New research from the University of North Carolina-Chapel Hill found that Novo N...
An NIH cap on indirect cost payments for grant recipients is casting a shroud of...